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Abstract: Spider venoms are a complex mixture of peptides with a large number of neurotoxins
targeting ion channels. Although thousands of peptide toxins have been identified from venoms of
numerous species of spiders, many unknown species urgently need to be investigated. In this study,
a novel sodium channel inhibitor, µ-TRTX-Hl1a, was identified from the venom of Haplopelma lividum.
It contained eight cysteines and formed a conserved cysteine pattern of ICK motif. µ-TRTX-Hl1a
inhibited the TTX-resistant (TTX-r) sodium channel current rather than the TTX-sensitive (TTX-s)
sodium channel current. Meanwhile, µ-TRTX-Hl1a selectively inhibited NaV1.8 with an IC50 value
of 2.19 µM. Intraperitoneal injection of µ-TRTX-Hl1a dose-dependently reduced inflammatory and
neuropathic pain in rodent models of formalin-induced paw licking, tail-flicking, acetic acid-induced
writhing, and hot plate test. It showed a better analgesic effect than morphine in inflammatory
pain and equipotent effect to morphine in neuropathic pain. These findings demonstrate that
µ-TRTX-Hl1a might be a valuable tool for physiology studies on NaV1.8 and a promising lead
molecule for pain therapeutics.
Keywords: spider; venom; neurotoxin; NaV1.8; analgesia
1. Introduction
About 46,340 species of spiders live in the world, but only 1407 spider toxins have been identified
from the venom of 97 species, whereas venom peptides from other species of spiders are still
unknown [1]. Numerous evidence demonstrates that spider venoms are complex chemical cocktails
and the major components are small, disulfide-rich neurotoxins. Most of the neurotoxins are sodium
Toxins 2017, 9, 7; doi:10.3390/toxins9010007 www.mdpi.com/journal/toxins
Toxins 2017, 9, 7 2 of 15
and calcium channel modulators. They can cause instant paralysis of prey, which may be a very
effective way for spiders to immobilize prey. The venom of Haplopelma lividum has not been well
characterized yet [2]. A case report of a finger bite from H. lividum showed that the venom caused
severe pain, implying that neurotoxins may exist in the venom [3].
Chronic pain is a major problem which plagues many people in the world and consequently
causes a significant economic loss [4]. Although the mechanism of pain is not well understood, it is
believed that voltage-gated sodium channels, including NaV1.8, play an important role. Voltage-gated
sodium channels (VGSCs) are integral transmembrane proteins distributed widely in most excitable
tissues and are essentially involved in the upstroke of action potentials [5,6]. They form the basis for
electrical signaling in the nervous system and control the flow of ions across the plasma membrane in
response to voltage changes [7]. So far, nine distinct subtypes of sodium channels (NaV1.1–NaV1.9)
have been cloned from a mammal. The TTX-resistant (TTX-r) NaV1.8 channel is mainly expressed in,
but not restricted to, the peripheral nervous system [8]. NaV1.8 mutations could produce peripheral
mechanical hypersensitivity and hyperexcitability in rat dorsal root ganglion (DRG) neurons [9,10].
Methylglyoxal could induce post-translational modifications of NaV1.8 [11]. Hence, the electrical
excitability and facilitated firing of nociceptive neurons were strongly increased to evoke thermal
and mechanical hyperalgesia. A-803467, a NaV1.8 channel blocker, could reduce allodynia in spinal
nerve ligation, sciatic nerve injury, capsaicin-induced secondary mechanical allodynia, and thermal
hyperalgesia [12].
In this work, a novel neurotoxin (µ-TRTX-Hl1a) with 39 amino acid residues was identified from
the venom of the spider H. lividum [13]. µ-TRTX-Hl1a showed a selective inhibition on the sodium
channel subtype NaV1.8. Tests in several animal models (formalin-induced paw licking, tail-flicking
test, hot plate test, and acetic acid-induced writhing) indicated that it has strong analgesic effects.
2. Results
2.1. Sequence Analysis of µ-TRTX-Hl1a
The original cDNA library of the H. lividum venom gland contained 1.5 × 106 independent clones
according to the protocol from cDNA library construction kit. To extract high-quality sequence,
vectors, primer sequences, poly (A) tails, and sequences shorter than 200 bp were excluded.
Finally, 381 EST sequences were generated by DNA sequencing. A peptide named µ-TRTX-Hl1a
with eight cysteines formed a conserved cysteine pattern of ICK motif (Figure 1B). As shown in
Figure 1, the full length of the cDNA open reading frame was 228 bp and encoded a 76-residue
precursor peptide. The peptide consisted of a signal peptide of 19 residues, a mature peptide of
39 residues and an intervening propeptide of 18 residues. The mature peptide of µ-TRTX-Hl1a
is TECGKKTWPCETSEDCCDGDCSDTYW TCHLGFGCTRICV. An online BLAST search showed
that µ-TRTX-Hl1a had considerable sequence similarity with other spider toxins such as JZTX-59
(U29-TRTX-Cj1a), toxic peptide C (U1-NETX-Csp1a) and Aps III (µ-CUTX-As1a). Toxic peptide C
and Aps III appear to be pore blockers and bind to the outer vestibule of insect voltage-gated sodium
channels [14–16].
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Buffer condition  Temperature (℃) Duration (h) pH  Folding Yield %
0.1 mol/L Tris‐HCl, 0.1 mol/L NaCl, 0.3 
mmol/L GSSG, 3 mmol/L GSH 
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4  48  6.8  8.46 
0.1 mol/L Tris‐HCl, 0.1 mol/L NaCl, 0.3 
mmol/L GSSG, 3 mmol/L GSH, 1 mol/L L‐Arg 
4  24  7.6  8.13 
4  24  7.4  8.53 
4  24  7.2  9.39 
4  24  6.8  10.38 
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Figure 1. Amino acid and cDNA sequence of µ-TRTX-Hl1a. (A) The cDNA sequence of µ-TRTX-Hl1a.
The sequence of the mature peptide is highlighted in black; and (B) alignm nt of µ- RTX-Hl1a
wit related spider toxins from Chilobrachys jingzhao (JZTX-59), Calisoga sp. (Toxic peptide C
(U1-NETX-Csp1a)), and Apomastus schlingeri (ApsIII (µ-CUTX-As1a)).
2.2. Synthesis and Refolding of µ-TRTX-Hl1a
In order to investigate its activity, µ-TRTX-Hl1a was synthesized as a linear peptide and its
molecular weight was the same as the theoretical weight (4354.85 Da). Then, 0.5 mg of µ-TRTX-Hl1a
was dissolved in different Tris-HCl buffers to test the folding yield to explore the best conditions for
refolding (Table 1). The molecular weight of refolded peptide was 4346.2 Da (Figure 2D). The folding
percentage was calculated by comparing areas of HPLC peaks for the linear and folded peptide.
Firstly, 0.1 mM Tris-HCl buffer with 0.3 mM GSSG and 3 mM GSH was used as a folding buffer and the
folding reaction was kept at different temperature for various duration. The highest folding percentage
under those co itions was 8.52% (Table 1). 0.5 M L-Arg was introduced to Tris-HCl buffer in order to
increase the folding rat . The folding perc ntages at pH 7.6, 7.4, 7.2, nd 6.8 were 8.13%, 8.53%, 9.39%,
and 10.38%, respectively. The folding percentage in the buffer (50 mM Tris-HCl, 50 mM NaCl, 0.15 mM
GSSG, 1.5 mM GSH, 0.5 M L-Arg) at pH 6.8 and 7.2 was 10.20% and 13.46%, respectively.
Table 1. Refold of µ-TRTX-Hl1a at different condition.
Buffer condition Temperature (°C) Duration (h) pH Folding Yield %
0.1 mol/L Tris-HCl, 0.1 mol/L NaCl, 0.3 mmol/L
GSSG, 3 mmol/L SH
25 24 7.2 6.04
4 24 7.2 7.08
4 24 6.8 8.52
4 48 6.8 8.46
0.1 mol/L Tris-HCl, 0.1 mol/L NaCl, 0.3 mmol/L
GSSG, 3 mmol/L GSH, 1 mol/L L-Arg
4 24 7.6 8.13
4 24 7.4 8.53
4 24 7.2 9.39
4 24 6.8 10.38
0.05 mol/L Tris-HCl, 0.05 mol/L NaCl,
0.15 mmol/L GSSG, 1.5 mmol/L GSH
4 24 7.2 10.20
4 24 6.8 13.46
As shown in Figure 2, the ret ntion time of the linear peptide was 42.1 min with an average
molecular mass of 4354.6 Da, while the folded peptide was eluted at 38.6 min and had molecular
mass of 4346.2 Da. The fact that the mo ecular mass of the refolded peptide was 8 Da less than that of
the linear form indicates that four disulfide bonds were formed.
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Figure 2. Identification of linear and refolded µ-TRTX-Hl1a; (A) the linear µ-TRTX-Hl1a was
analyzed by C18 RP-HPLC. The elution was performed with the gradients of acetonitrile in 0.1%
(v/v) trifluoroacetic acid in water at a flow rate of 1 mL/min. The gradient of acetonitrile was increased
from 10% to 50% during the time of 10 to 50 min; (B) ALDI-TOF- S determination of the molecular
weight of linear µ-TRTX-Hl1a; (C) the refolded µ-TRTX-Hl1a was purified on C18 RP-HPLC. The elution
was performed with the gradients of acetonitrile in 0.1% (v/v) trifluoroacetic acid in water at a flow
rate of 1 mL/min. The gradient of acetonitrile was increased from 10% to 50 during the time of 10 to
50 min; (D) MALDI-TOF-MS determination of the molecular weight of refolded µ-TRTX-Hl1a.
2.3. The Secondary Structure and Disulfide Bond of µ-TRTX-Hl1a
The peptide sequence of µ-TRTX-Hl1a was searched against the PDB protein structure database.
It matched well with insecticidal spider-venom p ptid Aps III (PDB id: 2M36) with high confidence
(92.64%) and 35 amino a id residues wer identical to each other, including the eig t Cys residues.
The disulfi e bonds f µ-TRTX-Hl1a w re determined by on-line seco dary structure modeling
(on-line Phyre 2 tool [17], combined ith protease digestion followed by MALDI-TOF-TOF-MSMS
characterization. The insecticidal spider-ven m p ptid Aps III has 38 amino acid residues containing
eight Cys residues forming four disulfide bonds. However, in the predicted secondary structure model,
only three di ulfide bonds (Cys3–Cys17, Cys10–Cys21, and Cys16–Cys38) w re predicted with high
confidence. Therefore, we used multiple protease digestions followe by MALDI-TOF/TOF-MSMS to
analyze whether Cys28 and Cys34 form a disulfide bond. The peptide was digested with Trypsin/Lys-C
Mix and Asp-N and 14-amino-acid-residue peptide (DTYWTCHLGFGCTR) containing Cys 28 and
Cys34 was generated and identified e hibiting a molecul r mass of 1657.78 by MS/MS (Figure 3A).
Its theoretical molecular mass was 2 Da higher than the detected one, which in icated that there was
a disulfide bond between Cys28 and Cys34. In summary, four disulfide bonds were identified and
paired in µ-TRTX-Hl1a as Cys3–Cys17, Cys10–Cys21, Cys16–Cys38, and Cys28–Cys34. The predicted
secondary str cture an disulfide bonds of µ-TRTX-Hl1 were presented with JSmolviewer (Figure 3B).
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between μ‐TRTX‐Hl1a and  the  sodium channel did not change  ion selectivity  (Figure 4C).  In  the 
presence of 5 μM μ‐TRTX‐Hl1a, conduction‐voltage (G‐V) relationship of sodium channel did not 
change. The estimated midpoint values of conductance‐voltage relationship before and after toxin 
Figure 3. The MS spectra for mapping of the disulfide bond between Cys28 and Cys34 and the predicted
secondary structure of µ-TRTX-Hl1a. (A) The MS/MS spectrum of peptide DTYWTCHLGFGCTR;
and (B) the secondary structure and disulfide bonds of µ-TRTX-Hl1a predicted by Phyre 2. In the
figure, the disulfide bonds are indicated in yellow line, alpha helices were shown as “yellow rockets”,
beta strands were shown as “purple planks”; arrowheads point towards the carboxyl termini, random
coils were colored in white, and turns were colored in blue.
2.4. Effects of µ-TRTX-Hl1a on VGSCs
The investigation of the biological function of µ-TRTX-Hl1a was performed on adult rat DRG
neurons by using the whole-cell patch-clamp technique. Cells were held at −80 mV for over 5 min
to allow adequate equilibration. Currents were elicited by a 50 ms depolarizing potential of −10 mV
from a holding potential of −80 every 5 s [18]. However, as shown in Figure 4A, about 72%
of -resistant ( TX-r) currents were inhibited by 5 µM µ-TRTX-Hl1a and the inhibition was
dose-d pendent with an IC50 value of 3.76 ± 0.10 µM (Figure 4B).
The current-voltage (I-V) c r TX-r sodium channel showed hat he toxin did not alter
the in tial activated volt ge and the reversal potentials of sodium channels, imply g that the
interactio between µ-TRTX-Hl1a and the sodium cha nel did not change ion selectivity (Figure 4C).
In the presence of 5 µM µ-TRTX-Hl1a, conduction-voltage (G-V) relationship of sodium channel did
not change. The estimated midpoint values of conductance-voltage relationship before and after
toxin treatment were −5.20 and −8.6 mV, respectively (Figure 4D). The effects of µ-TRTX-Hl1a on
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steady-state inactivation of TTX-r sodium channel of DRG neuron were illustrated in Figure 4E. No shift









currents  before  (solid  circles)  and  after  (open  circles)  application  of  5  μM  μ‐TRTX‐Hl1a;  (D) 





We have demonstrated  that μ‐TRTX‐Hl1a  inhibited TTX‐r sodium currents  in adult rat DRG 
neurons, but  showed no  effect on TTX‐sensitive  sodium  currents  at  the  concentration of  10  μM. 
Therefore, the activities of μ‐TRTX‐Hl1a on human sodium channel subtypes NaV1.1–NaV1.8 were 
further investigated. Sodium channel subtypes β1 and eGFP were transiently transfected into ND7/23 
Figure 4. Effect of µ-TRTX-Hl1a on voltage-gated ion channels in rat DRG neurons. (A) Inhibition of
TTX-r NaV channel currents by 5 µM µ-TRTX-Hl1a; (B) dose-dependent inhibition of µ-TRTX-Hl1a
on TTX-r NaV channel currents (n = 5); (C) current-voltage (I-V) relationship for the TTX-r NaV
channel currents before (solid circles) and after (open circles) application of 5 µM µ-TRTX-Hl1a;
(D) conductance-voltage (G-V) relationship for the TTX-r NaV channel before (solid circles) and after
(open circles) treatment of 5 µM µ-TRTX-Hl1a (n = 5); and (E) steady-state inactivation of the TTX-r
NaV channel currents before (solid circles) and after (open circles) application of 10 µM µ-TRTX-Hl1a
(n = 5).
2.5. Effects of µ-TRTX-Hl1a on NaV1.8
We have demonstrated that µ-TRTX-Hl1a inhibited TTX-r sodium currents in adult rat DRG
neurons, but showed no effect on TTX-sensitive sodium currents at the concentration of 10 µM.
Therefore, the activities of µ-TRTX-Hl1a on human sodium channel subtypes NaV1.1–NaV1.8 were
further investigated. Sodium channel subtypes β1 and eGFP were transiently transfected into ND7/23
cells and currents were elicited by a depolarizing potential of −10 mV from a holding potential
of −80 mV. 2 µM µ-TRTX-Hl1a could reduce about 50% of the NaV1.8 current and the inhibition
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was dose-dependent (Figure 5A). The IC50 value of µ-TRTX-Hl1a on NaV1.8 was 2.19 ± 0.07 µM
(Figure 5B). Furthermore, no inhibition was found in the other subtypes (Nav1.1–1.7) of sodium
channel (Figure S1). µ-TRTX-Hl1a at a concentration of 2 µM did not induce the shift of current-voltage
(I-V) relationship and conductance-voltage (G-V) relationships of sodium channel subtype NaV1.8







S1).  μ‐TRTX‐Hl1a  at  a  concentration  of  2  μM  did  not  induce  the  shift  of  current‐voltage  (I‐V) 
l tionship and conductance‐voltage (G‐V) relationships of sodium channel subtype NaV1.8 (Figure 





2  μM  μ‐TRTX‐Hl1a on  the  currents of NaV1.8;  (B) dose‐dependent  inhibition of  μ‐TRTX‐Hl1a on 
Figure 5. Effect of µ-TRTX-Hl1a on Nav1.8 expressed in ND7/23 cells; (A) current traces were evoked
by a 50-ms step depolarization to −10 mV from a holding potential of −80 mV every 5 s. The effect
of 2 µM µ-TRTX-Hl1a on the currents of NaV1.8; (B) dose-dependent inhibition of µ-TRTX-Hl1a
on NaV1.8 channel; (C) the current-voltage (I-V) relationship for NaV1.8 channel currents before
(solid circles) and after (open circles) application of 2 µM µ-TRTX-Hl1a; (D) the conductance-voltage
(G-V) relationship for NaV1.8 channel before (solid circles) and after (open circles) treatment of 2 µM
µ-TRTX-Hl1a (n = 5); and (E) steady-state inactivation of NaV1.8 channel currents before (solid circles)
and after (open circles) application of 10 µM µ-TRTX-Hl1a (n = 5).
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2.6. Effects of µ-TRTX-Hl1a on Pain
Since NaV1.8 is a significant analgesic drug target, the analgesic effect of µ-TRTX-Hl1a was tested
in several animal models including formalin-induced paw licking, tail-flicking, acetic acid-induced
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6A,B). In the early phase, the paw licking times were 146, 127, and 49 s for 1, 10, and 100 μM/kg μ‐
















induced paw  licking  response  in mice;  (B) effects of  μ‐TRTX‐Hl1a on  the  late phase of  formalin‐
Figure 6. ffects of µ-TRTX-Hl1a on pain. (A) Effects of µ-TRTX-Hl1a on t e early phase of
formalin-induced paw licking response in mice; (B) effects of µ-TRTX-Hl1a on the late phase of
formalin-induced paw licking response in mice; (C) eEffects of µ-TRTX-Hl1a on the hot plate test in
mice; (D) effects of µ-TRTX-Hl1a on the acetic acid-induced writhing response in mice; and (E) effects
of µ-TRTX-Hl1a on tail flicking test in mice. All data points are shown as mean ± S.E. Six animals were
used for each separate group experiment. * p < 0.05, ** p < 0.01 significantly different results compared
to the saline group.
Two time phases, including the early phase (0–15 min, neurogenic pain) and the late phase
(15–30 min, inflammatory pain), were recorded in response to formalin-induced paw licking. In the
control mice group, paw licking time was 205 s in the early phase and 592 s in the late phase
(Figure 6A,B). In the early phase, the paw licking times were 146, 127, and 49 s for 1, 10, and 100 µM/kg
µ-TRTX-Hl1a, respectively, while the numbers were 94, 71, and 60 s after injection of the same
concentrations of morphine (Figure 6A). In the late phase, the paw licking times were reduced to 341,
210, and 136 s for mice treated by 1, 10, and 100 µM/kg µ-TRTX-Hl1a, respectively, while the values
were decreased to 421, 275, and 211 s after injection of the same concentrations of morphine (Figure 6B).
In the hot plate test, a strong analgesic effect was observed after administration of µ-TRTX-Hl1a
or morphine. Compared with the latency of control (9 s), the latencies of mice treated by 1, 10,
and 100 µM/kg µ-TRTX-Hl1a was 13.5, 14.5, and 16.4 s, respectively. The latencies of 1, 10, and 100
µM/kg morphine were 12.5, 14.3, and 18.6 s, respectively (Figure 6C). In the acetic acid-induced
writhing test, intraperitoneal injection of 1, 10, and 100 µM/kg µ-TRTX-Hl1a reduced the duration
of writhing from 44.3 to 23.8, 11, and 3.5, respectively, while injection of 1, 10, and 100 µM/kg
morphine caused a reduction to 18, 9, and 3, respectively (Figure 6D). As illustrated in Figure 6E,
the tail withdrawal latency was 4.4 s in the control group. After treatment with 1, 10, and 100 µM /kg
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µ-TRTX-Hl1a, the latency of mice was 5.8, 7, and 9 s, respectively. Meanwhile, the latencies of mice
treated with the same concentrations of morphine were 6.8, 8.9, and 11.3 s, respectively.
3. Discussion
Animal venoms are a rich source of peptides and thousands of peptide toxins have been found
in venoms. Some peptides have shown high affinity and selectivity for a diverse range of biological
targets, especially membrane proteins, such as ion channels, receptors, and transporters [2,19].
Six drugs derived from venom peptides or proteins (captopril, eptifibatide, ziconotide, exenatide,
tirofiban, and bivalirudin) have been approved by the Food and Drug Administration [20]. Therefore,
peptide toxins may be a new library for modern drug discovery. H. lividum, as one tarantula species
of spiders in Southeast Asia, has never been intensively investigated so far. Only glutamic acid,
histamine, and adenosine were identified from the venom of H. lividum, while no peptide toxin has
been reported [21].
In this study, we described the identification and functional characterization of a novel neurotoxin
µ-TRTX-Hl1a from the spider venom of H. lividum. It consists of 39 residues and four disulfide bonds.
µ-TRTX-Hl1a showed identity to some other spider toxins such as 72% to JZTX-59 (U29-TRTX-Cj1a),
45% to toxic peptide C (U1-NETX-Csp1a) and 39% to Aps III (µ-cyrtautoxin-As1a). Although JZTX-59
was considered to be a neurotoxin, its target is still unknown. Other two toxins, toxic peptide C
(U1-NETX-Csp1a) and Aps III (µ-cyrtautoxin-As1a), are insecticidal peptides.
Linear µ-TRTX-Hl1a was synthesized and different solutions were used to refold this peptide.
Technically, it is very hard to refold a peptide toxin with more than three disulfide bonds. In this work,
we found that the condition of low pH (6.8) and low temperature (4 ◦C) were the optimum conditions
for refolding of µ-TRTX-Hl1a. A variety of chemical additives, e.g., urea, guanidine hydrochloride
(Gu/HCl), and arginine, could improve refolding of disulfide-coupled proteins [22]. The refolding was
increased from 8.52% to 10.38% with the addition of 0.5 M L-Arg, but greatly increased the complexity
of refolded protein. Finally, half of the concentration of the salt (0.05 M Tris-HCl, 0.05 M NaCl, 0.15 mM
GSSG, 1.5 mM GSH) was applied and the percentage was increased from 8.52% to 13.46%. Thus,
low pH, low temperature, and low salt concentration may be helpful for refolding of peptides with
many disulfide bonds.
The cysteine pattern of µ-TRTX-Hl1a was similar to ApsIII, a toxin containing an atypical
ICK motif with a conserved cysteine pattern [16], indicating that they may adopt the same motif.
Structure modeling implied that three disulfide bonds of µ-TRTX-Hl1a matched with Aps III, but the
other bond (Cys 28 and Cys34) was uncertain. This cysteine framework was further determined by
protease digestion and MS identification, implying that µ-TRTX-Hl1a is an ICK motif-containing toxin.
Taken together, MS combined with structure prediction is an efficient way to determine the disulfide
bonds of a long-chain peptide.
Clinical genetic studies have demonstrated that sodium channel subtype NaV1.8 (SCN9A) is
a critical mediator of pain sensitization and it becomes an attractive target for the development
of novel analgesics [9]. Various commercially available compounds, such as menthol, lidocaine,
tetracaine, vinpocetine, ambroxol, lamotrigine, mexiletine, veratridine, and A-803467, interact with
NaV1.8, whereas very few animal toxins have been shown to reduce NaV1.8 currents. Recent studies
revealed that tarantula toxins (ProTx-I, ProTx-II, CcoTx1, CcoTx2, and CcoTx3) could inhibit rat NaV1.8
currents, but none selectively targeted NaV1.8 [23,24]. µ-TRTX-Hl1a did not alter the I-V relationship,
conduction-relationship, and steady-state inactivation. The mechanism of inhibition was very similar
to other spider toxins [25,26]. µ-TRTX-Hl1a selectively reduced the current amplitude of NaV1.8 with
an IC50 value of 2.19 µM without affecting other sodium subtypes (NaV1.1, NaV1.2, NaV1.4, NaV1.5,
NaV1.6, and NaV1.7). We did not find any effect of µ-TRTX-Hl1a on potassium channels and calcium
channels (Figure S2). Due to its highly selective activity on NaV1.8, µ-TRTX-Hl1a could be a valuable
tool for the study of structure-function of NaV1.8.
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As a highly selective inhibitor of NaV1.8, µ-TRTX-Hl1a may have analgesic effects. To confirm this
hypothesis, several experimental pain models, including formalin paw licking, tail flicking, hot plate
test, and abdominal writhing were used to analyze the analgesic effects of µ-TRTX-Hl1a. There was a
significant decrease of nociception in all the rodent models with almost the same efficacy to morphine
at the molar basis. In the formalin-induced pain model, µ-TRTX-Hl1a showed an equipotent or less
analgesic effect to morphine in the early phase, whereas a higher analgesic effect than morphine was
observed in the later phase (Figure 6A,B). µ-TRTX-Hl1a was slightly less effective than morphine in
the tail-flicking test and hot plate test, but showed a better effect in an acetic acid-induced writhing test
(Figure 6C–E). This is consistent with the previous reports that inhibition of NaV1.8 elicited analgesic
effects in neuropathic and inflammatory pain. In our study, µ-TRTX-Hl1a was more effective on
inflammatory pain than on neuropathic pain, implying NaV1.8 may have different effects on the two
different kinds of pain.
This study intensively characterized the secondary structure and biological activity of
µ-TRTX-Hl1a, which is the first neurotoxin identified from the venom of H. lividum. Its highly selective
activity for NaV1.8 indicates that µ-TRTX-Hl1a is a potential tool for the study of the physiology of
NaV1.8. At the same time, it could be a lead compound or template for the development of novel
analgesic agents.
4. Materials and Methods
4.1. cDNA Synthesis
Total RNA was extracted from the venom glands of the spider using TRIzol (Thermo Fisher
Scientific, Waltham, MA, USA) and checked by visualizing the 28S, 18S, and 5S bands of ribosomal
RNA. cDNA library was constructed by using a SMART™ PCR cDNA synthesis kit (Clontech,
Palo Alto, CA, USA) [14]. The first strand was synthesized by using the 3′ SMART CDS Primer
II A (5′ AAGCAGTGGTATCAACGCAGAGTACT(30)N-1N 3′, where N = A, C, G, or T and N-1 = A,
G, or C) and SMART II A oligonucleotide (5′ AAGCAGTGGTATCAACGCAGAGTACGCGGG 3′).
The 5′ PCR primer II A (5′ AAGCAGTGGTATCAACGCAGAGT 3′) provided by the kit was used to
synthesize the second strand using Advantage Polymerase (Clontech, Palo Alto, CA, USA).
4.2. cDNA Sequence and Bioinformatics Analysis
PCR was performed with the M13 forward and reverse primers in the kit to rapidly screen
recombinant clones. The clones from original cDNA library were separated on LB agar plates.
The resulting colonies were randomly picked and sequenced with standard M13 reverse primers
on an ABI 3730 (ABI, Waltham, MA, USA) automatic DNA sequencer according to the manufacturer’s
instructions. The sequences of ESTs were translated into amino acid sequences following the forward
three frames using the software Jemboss 1.3 (EMBOSS, London, UK). The signal peptide was predicted
with the SignalP 4.1 program [27].
4.3. Peptide Synthesis and Refolding
The peptide predicted based on the sequences of ESTs was synthesized with solid-phase
methodology using a Boc protection strategy in GL Biochem Ltd. (GL Biochem, Shanghai, China).
The linear peptides (0.1 mg) were dissolved in 1 mL different renaturation solutions of different
pH (Table 1). 10 µL 50% TFA was used to terminate the reaction. After oxidization and refolding,
the oxidized peptide was isolated by analytical RP-HPLC on the C18 preparative column at 280 nm.
4.4. Mass Spectrometric Analysis
The purified peptide was dissolved in 0.1% (v/v) trifluoroacetic acid and 0.5 µL was
spotted onto a matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) plate with
0.5 µL α-cyano-4-hydroxycinnamic acid matrix (10 mg/mL in 60% acetonitrile). Spots were
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analyzed by an UltraFlex I mass spectrometer (Bruker Daltonics, Bremen, Germany) in a positive
ion mode to determine the molecular mass of the linear and refolded peptides according to
manufacturer’s instruction.
4.5. Digestion of the Peptide
Multiple proteases were used to generate peptide fragments with disulfide bond. In the
experiment, 50 µg of refolded µ-TRTX-Hl1a was dissolved in 100 µL of l50 mM triethylammonium
bicarbonate and firstly digested with Trypsin/Lys-C Mix (Promega, Copenhagen, Denmark) (2%, w/w)
at 37 ◦C overnight. The tryptic peptide was then subjected to AspN (Promega, Copenhagen, Denmark)
digestion (4%, w/w) at 37 ◦C for 15 h.
4.6. MALDI-TOF/TOF-MSMS
The purified peptide and digested peptide fragments after each protease treatment were desalted
by reversed phase chromatography using Poros Oligo R3 reversed-phase material staged in GE Loader
tips. Retained peptides were eluted onto a stainless-steel target plate using 70% ACN in 1% TFA
containing 5 mg/mL α-CHCA. Mass spectra were acquired on an Ultraflex II MALDI–TOF/TOF
(tandem TOF) mass spectrometer controlled by flexControl software (version 2.4, Bruker Daltonics,
Bremen, Germany). The instrument was operated in the positive reflector ion detection mode,
and spectra were recorded in the mass range of m/z 500–4000. Typically, signals from 1000 laser
shots (10 × 100 shots at 10 different positions) were averaged. Spectra were externally calibrated
using a tryptic lactoglobulin. Mass spectra were analyzed with Flex-Analysis software (version 2.4,
Bruker Daltonics, Bremen, Germany). For MALDI–TOF/TOF analysis, the window for precursor ion
selection was set to be ±1% of the mass of the precursor ion.
4.7. Structure Prediction and Modeling
The structure was predicted and modeled using the on-line Phyre 2 tool [17] and JSmolviewer
following the instructions.
4.8. Patch Clamp Recording on Rat Dorsal Root Ganglion (DRG) Neurons
Thirty-day-old adult Sprague-Dawley rats of either sex were decapitated. Then the dorsal root
ganglia were isolated quickly from the spinal cord [20]. The dissociated cells were suspended in
essential Dulbecco’s modified Eagle’s medium containing trypsin (0.5 g/L, type III), collagenase
(1.0 g/L, type IA), and DNase (0.1 g/L, type III) to incubate at 34uC for 30 min. Trypsin inhibitor
(1.5 g/L, type II-S) was used to terminate enzyme treatment. The DRG cells were transferred into
a 35-mm culture dish. Rat DRG neurons were acutely dissociated and maintained in a short-term
primary culture. Ca2+, Na+, and K+ currents were recorded from cells using the whole-cell patch
clamp technique with an Axon Multiclamp 700B amplifier (Molecular Devices, CA, USA). The P/4
protocol was used to subtract linear capacitive and leakage currents. For sodium current recordings
on DRG cells, the bath solution contained (in mM): 150 NaCl, 2 KCl, 5 D-glucose, 1 MgCl2, 1.5 CaCl2,
and 10 HEPES at pH 7.4; the pipette internal solution contained (in mM): 105 CsF, 35 NaCl, 10 HEPES,
and 10 EGTA at pH 7.4. For potassium channel, pipettes were filled with a solution containing (in mM)
76 K2SO4, 10 KCl, 10 NaCl, 1 MgCl2 and 5 HEPES, pH adjusted to 7.4, with KOH. The external solution
was (in mmol/l) 140 NaCl, 3.6 KCl, 2 NaHCO3, 0.5 NaH2PO4, 2.6 CaCl2, 0.5 MgSO4, and 5 HEPES,
pH 7.4. For the calcium channel, the standard intracellular solution contained (in mM): 135 CsCl;
3 MgCl2; 10 EGTA; 10 HEPES; 3 Mg-ATP; 0.6 GTP (pH 7.4 adjusted with CsOH). The standard bath
solution contained (in mM): 150 TEA-Cl; 2 CaCl2; 10 HEPES; 10 glucose (pH 7.4 adjusted with CsOH).
LVA currents were measured by 50 ms square voltage pulses to −40 mV from a holding potential of
−90 mV. Recordings were sampled at 4 kHz.
The patch pipettes with DC resistances of 2–3 M were fabricated from borosilicate glass tubing
(VWR micropipettes, 100 mL, VWR, Radnor, PA, USA) using a two-stage vertical microelectrode
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puller (PC-10, Narishige, Tokyo, Japan) and fire-polished by a heater (Narishige, Tokyo, Japan). All of
the experimental protocols using animals in this work were approved by the Animal Care and Use
Committee of Kunming Institute of Zoology, Chinese Academy of Sciences (2014-204, 14 October 2014).
4.9. Patch Clamp Recording on Sodium Channel Subtypes
Human sodium channel subtype Nav1.1–Nav1.7 were transiently transfected into HEK293T cells
and NaV1.8, β1, and eGFP were transiently transfected into ND7/23cells following the manufacture
instruction (lipo2000, Invitrogen, Carlsbad, CA, USA). The whole cell patch clamp recordings were
carried out as previously described [28]. The standard pipette solution contained (in mM) 140 CsF,
1 EGTA, 10 NaCl, 3 KCl, and 10 MgCl2, PH 7.3. The standard bathing solution was (in mM) 140 NaCl,
3 KCl, 1 MgCl2, 1 CaCl2, and 10 HEPES, pH 7.3.
4.10. Formalin-Induced Paw Licking
A formalin test was performed according to the method described by Owoyele et al. [29].
Mice were intraperitoneally (i.p.) injected with test samples dissolved in 100 µL of saline and positive
control animals were intraperitoneally injected with morphine dissolved in saline. The control group
received the same volume of saline. Animals were injected with 20 µL of 5% formalin at the plantar
surface of right hind paw after intraperitoneally injected with test samples. They were then placed into
open polyvinyl cages (20 cm × 40 cm × 15 cm) individually. The time spent for licking the injected
paw by each mouse was recorded by a digital video camera (early phase or neurogenic pain, 0–15 min
post-injection and late phase or inflammatory pain, 15–30 min post-injection).
4.11. Tail-Flicking Test
Mice with pain threshold of 4–6 s were selected for the tail-flicking test. Test samples (morphine
and µ-TRTX-Hl1a) were dissolved in saline. A photothermal pain detector (YLS-12A, Jinan, Shandong,
China) was used to measure the pain threshold of mice subjected to intense heat and the light beam
of the detector was focused on the middle of mouse tail. All of the animals were intraperitoneally
injected with saline containing different concentrations of samples and control group received the
same volume of saline [30]. Tail withdrawal latency was measured as the time taken to withdraw the
tail from the light beam.
4.12. Abdominal Writhing Response Caused by Acetic Acid
According to the method described by Santos et al. [31], mice were immediately intraperitoneally
injected with saline containing different concentrations of samples after intraperitoneal injection
of 200 µL of 0.8% (v/v) acetic acid. The control group received the same volume of saline.
After challenging, mice were placed into open polyvinyl cages (20 × 40 × 15 cm) individually, and the
abdominal writhing responses were counted for 30 min continuously.
4.13. Hot Plate
A hot plate apparatus (model HZ66-ZH-YLS-6B, Shanghai, China), maintained at 55 ± 1 ◦C,
was used to test the pain in response to a thermal stimulus [32]. Mice in the control condition showing
initial nociceptive responses between 5 and 10 s were selected for the experiment. The latency to the
sign of hind paw licking or jumping to avoid heat nociception was taken as the index of the nociceptive
threshold. Measurements were immediately started after treatment of the animals with µ-TRTX-Hl1a
or the vehicle. A group of mice treated with morphine dissolved in physiological saline was used as a
positive control. The vehicle used alone had no effect on nociceptive responses.
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4.14. Statistics
4.14.1. Data analysis for Patch Clamp
Experiments data were acquired and analyzed by using Clampfit 10.0 (Molecular Devices,
Sunnyvale, CA, USA) and Sigmaplot (Systat Software Incx, San Jose, CA, USA) programs. Data were
analyzed using the Clampfit (Axon, Sunnyvale, CA, USA) and Sigmaplot 9.0 (Systat Software Incx,
San Jose, CA, USA) software programs. All data points are shown as mean ± S.E. n represents the
number of the separate experimental cells. Dose-response curves were fitted using the following
Hill logistic equation: y = 1 − (1 − fmax)/(1 − ([Tx]/IC50)n), where n is an empirical Hill
coefficient and fmax is the fraction of current resistant to inhibition at high toxin concentration
(Tx). Conductance (G)–voltage relationships were determined from peak current (I) versus voltage
relationships as G = I/(V − Vrev), where V was the test potential, and Vrev was the extrapolated
reversal potential. Data were analyzed by using GraphPad Prism 4.
4.14.2. Data Analysis of the Animal Model
The results are expressed as the mean ± standard error of the mean (SEM). Statistical significance
was calculated using one- or two-way analysis of variance followed by the Student-Newman-Keuls
and Bonferroni’s post hoc tests. Significance was defined as p < 0.05.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/9/1/7/s1, Figure S1
µ-TRTX-Hl1a showed no effect on Nav1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.5, Nav1.6 and Nav1.7. Figure S2
µ-TRTX-Hl1a showed no effect on KV (A) currents and CaV (B) currents of DRG neurons.
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